BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Douillard V, Castelli EC, Mack SJ, Hollenbach JA, Gourraud PA, Vince N, Limou S; Covid-19|HLA & Immunogenetics Consortium and the SNP-HLA Reference Consortium. Current HLA Investigations on SARS-CoV-2 and Perspectives. Front Genet 2021;12:774922. [PMID: 34912378 DOI: 10.3389/fgene.2021.774922] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen L, Nersisyan S, Wu C, Chang C, Tonevitsky A, Guo C, Chang W. On the peptide binding affinity changes in population-specific HLA repertoires to the SARS-CoV-2 variants Delta and Omicron. Journal of Autoimmunity 2022. [DOI: 10.1016/j.jaut.2022.102952] [Reference Citation Analysis]
2 Bubnova L, Pavlova I, Terentieva M, Glazanova T, Belyaeva E, Sidorkevich S, Bashketova N, Chkhingeria I, Kozhemyakina M, Azarov D, Kuznetsova R, Ramsay ES, Gladkikh A, Sharova A, Dedkov V, Totolian A. HLA Genotypes in Patients with Infection Caused by Different Strains of SARS-CoV-2. IJERPH 2022;19:14024. [DOI: 10.3390/ijerph192114024] [Reference Citation Analysis]
3 Basir HRG, Majzoobi MM, Ebrahimi S, Noroozbeygi M, Hashemi SH, Keramat F, Mamani M, Eini P, Alizadeh S, Solgi G, Di D. Susceptibility and Severity of COVID-19 Are Both Associated With Lower Overall Viral–Peptide Binding Repertoire of HLA Class I Molecules, Especially in Younger People. Front Immunol 2022;13:891816. [DOI: 10.3389/fimmu.2022.891816] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zheng S, de Buhr H, Praest P, Evers A, Brak-boer I, van Grinsven M, Longo Y, de Vries L, Nijenhuis W, Kapitein LC, Beekman JM, Nijhuis M, Drexler I, Wiertz EJHJ, Lebbink RJ. The SARS-CoV-2 accessory factor ORF7a downregulates MHC class I surface expression.. [DOI: 10.1101/2022.05.29.493850] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Avetyan D, Hakobyan S, Nikoghosyan M, Ghukasyan L, Khachatryan G, Sirunyan T, Muradyan N, Zakharyan R, Chavushyan A, Hayrapetyan V, Hovhannisyan A, Mohamed Bakhash SA, Jerome KR, Roychoudhury P, Greninger AL, Niazyan L, Davidyants M, Melik-andreasyan G, Sargsyan S, Nersisyan L, Arakelyan A. Molecular Analysis of SARS-CoV-2 Lineages in Armenia. Viruses 2022;14:1074. [DOI: 10.3390/v14051074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Mocci S, Littera R, Tranquilli S, Provenzano A, Mascia A, Cannas F, Lai S, Giuressi E, Chessa L, Angioni G, Campagna M, Firinu D, Del Zompo M, La Nasa G, Perra A, Giglio S. A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited From Neanderthals in the Sardinian Population. Front Immunol 2022;13:891147. [PMID: 35514995 DOI: 10.3389/fimmu.2022.891147] [Reference Citation Analysis]
7 Hensen L, Illing PT, Rowntree LC, Davies J, Miller A, Tong SYC, Habel JR, van de Sandt CE, Flanagan K, Purcell AW, Kedzierska K, Clemens EB. T Cell Epitope Discovery in the Context of Distinct and Unique Indigenous HLA Profiles. Front Immunol 2022;13:812393. [DOI: 10.3389/fimmu.2022.812393] [Reference Citation Analysis]
8 Niemi MEK, Daly MJ, Ganna A. The human genetic epidemiology of COVID-19. Nat Rev Genet 2022. [PMID: 35501396 DOI: 10.1038/s41576-022-00478-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
9 Douillard V, Castelli EC, Mack SJ, Hollenbach JA, Gourraud PA, Vince N, Limou S. Approaching Genetics Through the MHC Lens: Tools and Methods for HLA Research. Front Genet 2021;12:774916. [PMID: 34925459 DOI: 10.3389/fgene.2021.774916] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]